Essbio Valuation
Is ESSBIO-C undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ESSBIO-C when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ESSBIO-C (CLP9.95) is trading below our estimate of fair value (CLP32.7)
Significantly Below Fair Value: ESSBIO-C is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ESSBIO-C?
Other financial metrics that can be useful for relative valuation.
What is ESSBIO-C's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CL$262.93b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 3.5x |
Enterprise Value/EBITDA | 7.9x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does ESSBIO-C's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 13.3x | ||
ESVAL-C Esval | 19.1x | n/a | CL$553.5b |
IAM Inversiones Aguas Metropolitanas | 11.2x | 9.7% | CL$730.0b |
AGUAS-A Aguas Andinas | 12.3x | 21.3% | CL$1.6t |
GASCO Empresas Gasco | 10.8x | n/a | CL$191.3b |
ESSBIO-C Essbio | 8.9x | n/a | CL$262.9b |
Price-To-Earnings vs Peers: ESSBIO-C is good value based on its Price-To-Earnings Ratio (8.9x) compared to the peer average (13.3x).
Price to Earnings Ratio vs Industry
How does ESSBIO-C's PE Ratio compare vs other companies in the Global Water Utilities Industry?
Price-To-Earnings vs Industry: ESSBIO-C is good value based on its Price-To-Earnings Ratio (8.9x) compared to the Global Water Utilities industry average (16.6x).
Price to Earnings Ratio vs Fair Ratio
What is ESSBIO-C's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 8.9x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate ESSBIO-C's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.